Events

The American Conference Institute's 6th Annual Summit on Biosimilars will take place from Monday, June 01, 2015 through Wednesday, June 03, 2015, at the Affinia Manhattan, in New York, NY.

Biosimilars 2015 is the definitive forum on the Legal, Regulatory, and Commercial Realities of Biosimilars. Highlights of this year’s event include:

• Direct insights from the FDA on the biosimilars approval process including making an interchangeability determination, demonstrating safety and efficacy, and designating a name for the biosimilar
• A Judge’s panel featuring renowned jurists who will provide their insights into the issues involved in biosimilars litigation under the BPCIA and at the USPTAB
• Policy insiders who will talk about the battles in the state courts over substitution and naming
• Benchmarking against representatives from Boehringer, Genentech, Momenta, Fresenius, and many more featuring a new open floor town hall session to wrap up the conference

Whether you are on the innovator or biosimilars side, you will walk away with a nuanced plan for US biosimilars market entry.

On June 02, 2015, at 11:00 a.m., Orange County Partner Sheila Swaroop will be a panelist on, "Incorporating Inter-Partes Review and New USPTO Procedures Into Branded and Biosimilar Litigation Strategies". Seattle Partner Carol Pitzel Cruz will later be a panelist on, "The Next Battle Ground: Strategies for Obtaining or Challenging Preliminary Injunctions" at 2:15 p.m.